Mereo BioPharma Group plc - American Depositary Shares — Quarterly Cash Flow (NASDAQ:MREO) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Total assets 88.75 M76.39 M68.32 M62.63 M53.6 M Total liabilities 16.21 M15.42 M8.24 M8.45 M7 M Total equity 72.54 M60.97 M60.08 M54.18 M46.6 M Total liabilities & shareholders' equities 88.75 M76.39 M68.32 M62.63 M53.6 M Total debt ————— Net debt —————

Noticias

Mereo BioPharma Group plc (MREO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Cantor Fitzgerald maintains Overweight rating on Mereo BioPharma stock

Needham lowers Mereo BioPharma stock price target to $3 on trial data

Five Below To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Tuesday - American Eagle Outfitters (NYSE:AEO), Apellis Pharmaceuticals (NASDAQ:APLS)

Mereo BioPharma actualiza programa de setrusumab y extiende su liquidez

Mereo BioPharma actualiza programa de setrusumab y extiende liquidez

Mereo BioPharma updates setrusumab program, extends cash runway

BofA Securities reduce el precio objetivo de las acciones de Ultragenyx Pharma tras ensayos fallidos

BofA Securities reduce precio objetivo de Ultragenyx Pharma tras ensayos fallidos

BofA Securities lowers Ultragenyx Pharma stock price target on failed trials

Leerink reitera calificación de Mejor Rendimiento para acciones de Ultragenyx Pharma

Leerink reitera calificación de Ultragenyx Pharma en Outperform